
PREDEASY Helpdesk
Thank you for purchasing SOLVO PREDEASY™ ATPase Assay Kit product. The PREDEASY™ ATPase Kits include all reagents and solutions needed for the execution of both activation and inhibition assays. It is important to point out that the followings are required to run the assay successfully:
1. General laboratory practice (e.g. pipetting small volumes, 1 µls, etc. )
2. Product performance according to the data sheet specifications is only guaranteed if the assay steps are closely followed and recommended equipment and materials are used.
3. Recommended equipment and materials:
- Water bath / heating block / thermoshaker (BIOSAN PST-60HL or equivalent), 37 oC (Do not use CO2 incubator because of insufficient heat transfer!)
- Automatic pipettes, multichannel-pipette with corresponding tips (Eppendorf Research, Multipette Plus or equivalent, Eppendorf pipette tips or equivalent quality tips). Please note that the membrane suspension and solutions are provided in excess quantity, still it might not be sufficient for electronic pipettes.
- 96 well microtiter plates (COSTAR 3585 or equivalent)
- Microplate reader with absorbance filter suitable for measuring OD between 590 and 630 nm
- 2 ml, 5ml, 10 ml tubes
- MilliQ water (phosphate free water)
- Dimethyl sulfoxide (DMSO, A.C.S reagent spectrophotometric grade, >=99,9%, Sigma 154938)
5. If most of the 10 assays provided in a 10-plate size kit are done on separate days, it is recommended to aliquot the Assay mix (Vial B), the Developer (Vial G) and the Blocker (Vial H) after the first thawing, and keep the unused aliquots at -80oC until the day of usage. These ingredients might be sensitive to be thawed and frozen several times.
6. PREDEASY ATPase Kits include internal positive and negative controls. Controls which confirm that the transporter can be activated by a known substrate and the activated transporter can be inhibited by a known inhibitor are included as standard components of every protocol.
- Internal positive controls (CTRL3, CTRL5) in each assay are designed to validate the assay at one concentration point of the activator and inhibitor for each experiment.
- Vanadate control points serve as internal negative controls at each test drug concentration. Correction with vanadate control values helps to exclude any non-transporter specific vanadate insensitive effect.
PREDEASY-CTRL Assay Kits are additional controls. Negative control experiments applying control membranes are not used in any computations to determine transporter specific EC50, IC50 or maximal efficacy results. They provide quality type information, i.e. information about the origin of the effects. They can confirm positive answers in case of activation assays or they can help to exclude false positives.
Available PREDEASY negative control kits:
| ABC TRANSPORTER PREDEASY ATPase Kit | Relevant PREDEASY Negative Control Kit |
| MDR1-PREDEASY-ATPase Kit Assay Protocol | defPgp-PREDEASY-CTRL Kit Assay Protocol |
| ratMdr1b-PREDEASY-ATPase Kit Assay Protocol | betagal-PREDEASY-CTRL Kit Assay Protocol |
| MRP1-PREDEASY-ATPase Kit Assay Protocol | defMRP-PREDEASY-CTRL Kit Assay Protocol for MRP1 |
| MRP2-PREDEASY-ATPase Kit Assay Protocol | defMRP-PREDEASY-CTRL Kit Assay Protocol |
| MRP3-PREDEASY-ATPase Kit Assay Protocol | defMRP-PREDEASY-CTRL Kit Assay Protocol |
| BCRP-HAM-PREDEASY-ATPase Kit Assay Protocol | defBCRP-HAM-PREDEASY-CTRL Kit Assay Protocol |
| mouseBsep-HAM-PREDEASY-ATPase Kit Assay Protocol | betagal-PREDEASY-CTRL Kit Assay Protocol |
7. Suggested assay plate map for an activation and inhibition study. (Please note, that test article concentrations in the plate map are final concentrations!)
| Plate Map (for two parallels) | Controls | test drug (µM) | test drug (µM) + vanadate | test drug (µM) + activator | test drug (µM) + activator + vanadate | |||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| A | Blank | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 | |||
| B | 4 nmol Pi | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |||
| C | 8 nmol Pi | 33.33 | 33.33 | 33.33 | 33.33 | 33.33 | 33.33 | 33.33 | 33.33 | |||
| D | Ctrl1 | 11.11 | 11.11 | 11.11 | 11.11 | 11.11 | 11.11 | 11.11 | 11.11 | |||
| E | Ctrl2 | 3.70 | 3.70 | 3.70 | 3.70 | 3.70 | 3.70 | 3.70 | 3.70 | |||
| F | Ctrl3 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | |||
| G | Ctrl4 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | |||
| H | Ctrl5 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | |||
| Blank | Assay mix + 10 µl distilled water |
| 4 nmol Pi | Assay mix + 10 µl 0,4 mM Pi |
| 8 nmol Pi | Assay mix + 10 µl 0,8 mM Pi |
| Ctrl1 | Membrane suspension + 1µl solvent |
| Ctrl2 | Membrane suspension + vanadate (1,2 mM) + 1µl solvent |
| Ctrl3 | Membrane suspension + activator + 1µl solvent |
| Ctrl4 | Activated membrane suspension + vanadate (1,2 mM) + 1µl solvent |
| Ctrl5 | Activated membrane suspension + 1µl inhibitor |
| Membrane suspension + 1µl test drug form drug plate | |
| Membrane suspension + vanadate + 1µl test drug form drug plate | |
| Activated membrane suspension + 1µl test drug form drug plate | |
| Activated membrane suspension + vanadate + 1µl test drug form drug plate |
Video shots of the major and the most critical assay steps of a PREDEASY™ ATPase Detailed assay steps and videos (For registered visitors only)
Please write your question here:
